2023-08-04 13:08:14 ET
- Rapid Micro Biosystems press release ( NASDAQ: RPID ): Q2 GAAP EPS of -$0.33 beats by $0.02 .
- Net loss for the second quarter of 2023 was $14.0 million, compared to $13.1 million in the second quarter of 2022. The increase was primarily due to higher costs of revenue, partially offset by higher revenue and increased interest income.
- Revenue of $5M (+28.2% Y/Y) beats by $0.85M .
- Second quarter recurring revenue increased 44% to $3.6 million, including record consumable revenue
- Reaffirms full year 2023 total revenue guidance of at least $22.0 million, representing growth of approximately 30% compared to full year 2022
For further details see:
Rapid Micro Biosystems GAAP EPS of -$0.33 beats by $0.02, revenue of $5M beats by $0.85M